〔1〕 FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer Incidence and
Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012〔J〕. Int J Cancer,2015,136(5):E359-E386.
〔2〕 FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the Global
Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods〔J〕. Int J
Cancer,2019,144(8):1941-1953.
〔3〕 王宇,宋淑芳,刘凤.我国宫颈癌流行病学特征和发病高危因素的研究进展〔J〕.中国妇幼保健,2019,34(5):1206-1208.
〔4〕 WHITE R, MORGANSTEIN D, CHRISTIAN M, et al. Role of RIP140 in Metabolic Tissues: Connections to Disease〔J〕. FEBS Lett,2008,582(1):39-45.
〔5〕 POWELKA A M, SETH A, VIRBASIUS J V, et al. Suppression of Oxidative
Metabolism and Mitochondrial Biogenesis by the Transcriptional Corepressor RIP140 in Mouse Adipocytes〔J〕. J Clin Invest,2006,116(1):125-136.
〔6〕 DOCQUIER A, HARMAND P O, FRITSCH S, et al. The Transcriptional
Coregulator RIP140 Represses E2F1
Activity and Discriminates Breast Cancer Subtypes〔J〕. Clin Cancer
Res,2010,16(11):2959-2970.
〔7〕 LAPIERRE M, BONNET S, BASCOUL-MOLLEVI C, et al. RIP140 Increases APC
Expression and Controls Intestinal Homeostasis and Tumorigenesis〔J〕. J Clin Invest,2014,124(5):1899-1913.
〔8〕 SIXOU S, M?譈LLER K, JALAGUIER S, et al. Importance of RIP140 and
LCoR Sub-Cellular Localization for Their Association with Breast Cancer
Aggressiveness and Patient Survival〔J〕. Transl
Oncol,2018,11(5):1090-1096.
〔9〕 VATTAI A, CAVAILLES V, SIXOU S, et al. Investiga-tion of RIP140
and LCoR as Independent Markers for Poor Prognosis in Cervical Cancer〔J〕. Oncotarget,2017,8(62):105356-105371.
〔10〕 LAPIERRE M, DOCQUIER A, CASTET-NICOLAS A, et al. The Emerging Role of the
Transcriptional Coregulator RIP140
in Solid Tumors〔J〕. Biochim
Biophys Acta,2015,1856(1):144-150.
〔11〕 RAMACHANDRAN B. Functional
Association of Oestro-gen Receptors with HPV Infection in Cervical
Carcino-genesis〔J〕. Endocr Relat Cancer,2017,24(4):R99-R108.
〔12〕 CHEN H Z, TSAI S Y, LEONE G. Emerging Roles of E2Fs in
Cancer: An Exit from
Cell Cycle Control〔J〕. Nat Rev
Cancer,2009,9(11):785-797.
〔13〕 SRIVASTAVA P, MANGAL M, AGARWAL S M. Understanding the
Transcriptional Regulation of Cervix Cancer Using Microarray Gene Expression
Data and Promoter Sequence Analysis of a Curated Gene Set〔J〕. Gene,2014,535(2):233-238.
〔14〕 M?譈LLER K, SIXOU S, KUHN C, et al. Prognostic Relevance of
RIP140 and ERβ Expression
in Unifocal versus Multifocal Breast Cancers: A Preliminary Re-port〔J〕. Int J Mol
Sci, 2019, 20(2): 418.
〔15〕 ASIM M, HAFEEZ B B, SIDDIQUI I A, et al. Ligand-Dependent
Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by
the Src Protein Kinase〔J〕. J Biol Chem,2011,286(43):37108-37117.
〔16〕 WHITE J H, FERNANDES I, MADER S, et al. Corepressor Recruitment by
Agonist-Bound Nuclear Receptors〔J〕. Vitam Horm,2004,68:123-143.
〔17〕 VOGELSANG T L R, SCHMOECKEL E, KUHN C, et al. Regulation of LCoR and
RIP140 Expression in Cervical Intraepithelial Neoplasia and Correlation with
CIN Progression and Dedifferentiation〔J〕. J Cancer
Res Clin Oncol,2020,146(7):1847-1855.
|